BioPharma Partnering in Japan – December 18, 2017
Biopharma Partnering in Japan Biopharma Partnering in Japan This half an hour webinar will provide valuable education and insights into […]
Locust Walk Webinar
2024
Locust Walk Webinar
BioPharma Buy-Side Deal Process Keys to Success- June 13, 2017
BioPharma Buy-Side Deal Process Keys to Success BioPharma Buy-Side Deal Process Keys to Success The webinar will cover key issues
Locust Walk Webinar
Fundamentals and Key Trends in Life Sciences Private Financing- July 26, 2017
Fundamentals And Recent Trends in Life Sciences Private Financing Fundamentals And Recent Trends in Life Sciences Private Financing This one-hour,
Locust Walk Webinar
Biopharma Valuation Analysis
Webinar- Biopharma Valuation Analysis Biopharma Valuation Analysis The webinar will cover key issues surrounding how to best value a biopharma
News
Garuda Therapeutics Launches with $72 Million Series A Financing
LOCUST WALK NEWS Garuda Therapeutics Launches with $72 Million Series A Financing CAMBRIDGE, Mass.–(BUSINESS WIRE)–Garuda Therapeutics, a company creating off-the-shelf,
News
Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing
News
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
LOCUST WALK NEWS eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company
News
Locust Walk Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on March 1, 2021
LOCUST WALK NEWS Locust Walk Acquisition Corp. Class A Common Shares and Warrants to Commence Trading Separately on March 1,
News
Locust Walk Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option
LOCUST WALK NEWS Locust Walk Acquisition Corp. Announces Completion of $175,000,000 Initial Public Offering, Including Exercise of Over-Allotment Option PHILADELPHIA
Podcast
Biotalk Episode 15: 2024 Q1 Report: Global Trends in Biopharma Transactions
Podcast: Play in new window | Download (Duration: 11:03 — 25.3MB)
Subscribe: Apple Podcasts | Spotify | RSS
During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Q1 Report: Global Trends in Biopharma Transactions Report. Each quarter,